Patent Assignment
Reel/Frame 052251/0288
Change of Name
Recorded: 2020-03-27
Pages: 47
Assignor
ALFACELL CORPORATION
Executed: 2010-04-27
Assignee
TAMIR BIOTECHNOLOGY, INC.
51 JFK PARKWAY, SUITE 108, SHORT HILLS, NEW JERSEY, 07078
Covered Properties
(9)
Fusion Protein Incorporating a Cysteinized Ribonuclease
Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto
Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of a Known Amino Acid Sequence and an Initial N-Terminal Residue
Nucleic Acid Encoding Cysteinized Ribonuclease to Which a Targeting Moiety Can Be Conjugated
Nucleic Acid Encoding a Fusion Protein Incorporating a Cysteinized Ribonuclease
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.